FIELD: medicine.
SUBSTANCE: invention relates to a local hemostatic agent for stopping massive bleeding. Product contains chitosan salt, namely chitosan succinate or chitosan hydrochloride or chitosan ascorbate, sodium carboxymethyl cellulose (CMC-Na) and an antibiotic selected from the group of fluoroquinolones, namely, ciprofloxacin or pefloxacin or lomefloxacin in the following ratio, wt.%: Chitosan salt 56.00–74.92 %, CMC-Na 25–43.9 % and antibiotic 0.08–0.1 %.
EFFECT: tool is characterized by a high sorption capacity for blood, a short time of onset of hemostasis and increased antimicrobial activity.
3 cl, 2 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
LOCAL HAEMOSTATIC ANTIBACTERIAL AGENT | 2021 |
|
RU2776015C1 |
LOCAL HEMOSTATIC AGENT | 2013 |
|
RU2519220C1 |
LOCAL HEMOSTATIC AGENT | 2023 |
|
RU2807892C1 |
SINGLE TOPICAL APPLICATION HEMOSTATIC GEL MANUFACTURING METHOD | 2022 |
|
RU2789581C1 |
HEMOSTATIC AGENT BASED ON CHITOSAN AEROGEL | 2020 |
|
RU2743425C1 |
HEMOSTATIC GEL FOR SINGLE TOPICAL APPLICATION | 2023 |
|
RU2796161C1 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
HAEMOSTATIC AGENT | 2023 |
|
RU2826361C1 |
HEMOSTATIC AGENT BASED ON CHITOSAN | 2023 |
|
RU2807862C1 |
HAEMOSTATIC AGENT BASED ON CHITOSAN SUCCINATE AND CALENDULA EXTRACT | 2019 |
|
RU2694372C1 |
Authors
Dates
2018-12-21—Published
2018-10-02—Filed